SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-078272
Filing Date
2018-03-12
Accepted
2018-03-12 07:37:02
Documents
3
Period of Report
2018-03-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d549342d8k.htm 8-K 14974
2 EX-99.1 d549342dex991.htm EX-99.1 16485
3 GRAPHIC g549342g0311074303007.jpg GRAPHIC 2897
  Complete submission text file 0001193125-18-078272.txt   37000
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 18682035
SIC: 2834 Pharmaceutical Preparations